Optimising The Value Of Biomarkers In The Clinic Is To Be Discussed At SMi's Biomarkers In Clinical Trials Conference, 19-20 September 2011, London

SMi Group is proud to announce its 3rd annual Biomarkers in Clinical Trials conference, which will be held in London on 19th and 20th September 2011. Clinical trials are a costly necessity and when the decrease in drug discovery success rate is taken into account, finding new routes to streamlining them is essential in an era of mandatory efficiency. Expediting drugs while decreasing expense, lies at the heart of the rationale behind using biomarkers. Optimising clinical trials by virtue of biomarkers at R&D can improve decision making, allowing for later stage failure rates to be reduced...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/E4g9OJ6n7q0/232547.php

nutrition weight loss